Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-management of Sedative Therapy with Dexmedetomidine in Ventilated ICU Patients
NCT02819141Phase 3Completed
- Sponsor
- Mayo Clinic
- Start
- Nov 2016
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in anxiety disorder, sponsored by Mayo Clinic. Started Nov 2016; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT02819141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02819141.